Risk scores are statistical indicators based on prescribing patterns compared to specialty peers. They are NOT allegations of fraud, misconduct, or improper care. Many legitimate medical reasons can explain outlier prescribing.
Read our methodology →Risk Flags
Risk indicators are statistical patterns, not allegations. Learn more
12,740
Total Claims
$472K
Drug Cost
1,235
Beneficiaries
$382
Cost/Patient
Risk Score Breakdown 6/100
Score components are additive. Read full methodology
Peer Comparison vs. 106,889 Family Practice providers
-64%
Cost per patient vs peers
$382 vs $1,068 avg
-39%
Brand preference vs peers
5.5% vs 9.0% avg
Brand vs Generic
Brand: 695 claims · $251K
Generic: 11,952 claims · $220K
Top Prescribed Drugs
| Drug (Generic) | Claims | Cost |
|---|---|---|
| Sitagliptin Phosphate | 26 | $44K |
| Rivaroxaban | 24 | $37K |
| Apixaban | 26 | $29K |
| Rosuvastatin Calcium | 1,395 | $27K |
| Atorvastatin Calcium | 1,511 | $20K |
| Fluticasone/Vilanterol | 15 | $12K |
| Dexlansoprazole | 13 | $9,108 |
| Levothyroxine Sodium | 546 | $9,097 |
| Levothyroxine Sodium | 94 | $8,205 |
| Losartan Potassium | 468 | $7,518 |
| Ezetimibe | 204 | $7,301 |
| Metoprolol Succinate | 342 | $7,287 |
| Amlodipine Besylate | 813 | $6,076 |
| Pantoprazole Sodium | 305 | $4,686 |
| Omeprazole | 288 | $4,626 |
Prescribing Profile
Patient Profile
77
Avg Age
45%
Female
1.27
Avg Risk Score
Explore More
Data from CMS Medicare Part D Prescriber Public Use File, 2023. Risk scores are statistical indicators, not allegations of wrongdoing.Methodology · About · Dispute this data